Federated Hermes Inc. Has $12.88 Million Position in Bath & Body Works, Inc. $BBWI

Federated Hermes Inc. raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 1,629.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 430,024 shares of the company’s stock after buying an additional 405,158 shares during the quarter. Federated Hermes Inc. owned 0.20% of Bath & Body Works worth $12,884,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Bath & Body Works in the second quarter valued at about $33,000. SVB Wealth LLC acquired a new stake in Bath & Body Works during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Parallel Advisors LLC raised its holdings in shares of Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after buying an additional 481 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its holdings in shares of Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after buying an additional 364 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insider Transactions at Bath & Body Works

In other news, Director Lucy Brady bought 3,470 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was bought at an average price of $14.40 per share, for a total transaction of $49,968.00. Following the completion of the transaction, the director directly owned 17,482 shares in the company, valued at $251,740.80. The trade was a 24.76% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Francis Hondal purchased 3,343 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $14.99 per share, for a total transaction of $50,111.57. Following the purchase, the director directly owned 21,554 shares of the company’s stock, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 33,513 shares of company stock worth $500,442. Insiders own 0.26% of the company’s stock.

Bath & Body Works Stock Up 2.7%

Shares of NYSE:BBWI opened at $19.53 on Thursday. The firm has a market cap of $4.00 billion, a P/E ratio of 6.01, a P/E/G ratio of 0.70 and a beta of 1.51. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $41.87. The company’s 50-day moving average price is $22.55 and its two-hundred day moving average price is $26.84.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. Bath & Body Works’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, equities analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend was Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $38.00 to $17.00 in a research report on Friday, November 21st. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, November 21st. Baird R W cut shares of Bath & Body Works from a “strong-buy” rating to a “hold” rating in a research report on Friday, November 21st. JPMorgan Chase & Co. cut their price target on shares of Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday, November 20th. Finally, New Street Research set a $26.00 price objective on shares of Bath & Body Works in a research note on Monday, November 24th. Six investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $25.17.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.